HTL Stock Overview Develops, manufactures, and sells precision instruments, laboratory equipment, consumables, software, and services for the assisted reproductive technologies (ART), research, and cell biology markets. More details
Rewards Risk Analysis No risks detected for HTL from our risk checks.
See All Risk Checks Capture your thoughts, links and company narrative
Hamilton Thorne Ltd. Competitors Price History & Performance
Summary of share price highs, lows and changes for Hamilton Thorne Historical stock prices Current Share Price CA$2.24 52 Week High CA$2.25 52 Week Low CA$1.17 Beta 0.41 1 Month Change 0.45% 3 Month Change 4.67% 1 Year Change 85.12% 3 Year Change 6.67% 5 Year Change 111.32% Change since IPO 489.47%
Recent News & Updates
Astorg Completes Take Private of Hamilton Thorne Dec 03
Astorg Asset Management S A.R.L., Daniel Thorne and FAX Capital Corp. completed the acquisition of Hamilton Thorne Ltd (TSX: HTL) (the "Company") from FAX Capital Corp., Special Situations Life Sciences Fund, L.P managed by AWM Investment Company Inc, Daniel Thorne and others. Dec 01
Astorg Asset Management S A.R.L., Daniel Thorne and FAX Capital Corp. completed the acquisition of Hamilton Thorne Ltd (TSX: HTL) (the "Company") from FAX Capital Corp., Special Situations Life Sciences Fund, L.P managed by AWM Investment Company Inc, Daniel Thorne and others. Nov 30
Third quarter 2024 earnings: EPS misses analyst expectations Nov 17
Second quarter 2024 earnings released: US$0.003 loss per share (vs US$0.003 loss in 2Q 2023) Aug 15
Hamilton Thorne Ltd. to Report Q2, 2024 Results on Aug 14, 2024 Aug 07 See more updates
Astorg Completes Take Private of Hamilton Thorne Dec 03
Astorg Asset Management S A.R.L., Daniel Thorne and FAX Capital Corp. completed the acquisition of Hamilton Thorne Ltd (TSX: HTL) (the "Company") from FAX Capital Corp., Special Situations Life Sciences Fund, L.P managed by AWM Investment Company Inc, Daniel Thorne and others. Dec 01
Astorg Asset Management S A.R.L., Daniel Thorne and FAX Capital Corp. completed the acquisition of Hamilton Thorne Ltd (TSX: HTL) (the "Company") from FAX Capital Corp., Special Situations Life Sciences Fund, L.P managed by AWM Investment Company Inc, Daniel Thorne and others. Nov 30
Third quarter 2024 earnings: EPS misses analyst expectations Nov 17
Second quarter 2024 earnings released: US$0.003 loss per share (vs US$0.003 loss in 2Q 2023) Aug 15
Hamilton Thorne Ltd. to Report Q2, 2024 Results on Aug 14, 2024 Aug 07
A Piece Of The Puzzle Missing From Hamilton Thorne Ltd.'s (TSE:HTL) 47% Share Price Climb Jul 29
New minor risk - Share price stability Jul 23 Astorg Asset Management S A.R.L., Daniel Thorne and FAX Capital Corp. entered into a definitive arrangement agreement to acquire Hamilton Thorne Ltd (TSX: HTL) from FAX Capital Corp., Special Situations Life Sciences Fund, L.P managed by AWM Investment Company Inc, Daniel Thorne and others in an equity reinvestment transaction for approximately CAD 350 million. Jul 22
First quarter 2024 earnings: Revenues exceed analysts expectations while EPS lags behind May 16
Hamilton Thorne Ltd. to Report Q1, 2024 Results on May 14, 2024 May 08
Hamilton Thorne Ltd., Annual General Meeting, Jun 11, 2024 Apr 13
Full year 2023 earnings released: US$0.004 loss per share (vs US$0.013 profit in FY 2022) Mar 27
Hamilton Thorne Ltd. Provides Earnings Guidance for the First Quarter 2024 and Full Twelve Months of 2024 Mar 27
Hamilton Thorne Ltd. to Report Q4, 2023 Results on Mar 27, 2024 Mar 22 Hamilton Thorne Ltd. Announces CEO Changes, Effective January 15, 2024
New major risk - Revenue and earnings growth Nov 15
Hamilton Thorne Ltd. to Report Q3, 2023 Results on Nov 13, 2023 Nov 08
Hamilton Thorne Ltd. (TSX:HTL) agreed to acquire Gynetics Medical Products N.V. for an enterprise value of €18.3 million. Oct 12
Consensus EPS estimates increase by 80% Oct 12
New minor risk - Shareholder dilution Oct 11 Hamilton Thorne Ltd.(TSXV:HTL) dropped from S&P/TSX Venture Composite Index Sep 07
Consensus EPS estimates fall by 80% Aug 24
Second quarter 2023 earnings released: US$0.003 loss per share (vs US$0.002 profit in 2Q 2022) Aug 18
These 4 Measures Indicate That Hamilton Thorne (CVE:HTL) Is Using Debt Reasonably Well Aug 15
Hamilton Thorne Ltd. to Report Q2, 2023 Results on Aug 17, 2023 Aug 11
Consensus EPS estimates fall by 50% May 22
First quarter 2023 earnings released: EPS: US$0.001 (vs US$0.004 in 1Q 2022) May 16
Hamilton Thorne Ltd. to Report Q1, 2023 Results on May 15, 2023 May 09
Chair, President & CEO exercised options to buy CA$102k worth of stock. Apr 17
Chair, President & CEO recently sold CA$101k worth of stock Apr 16
Full year 2022 earnings: EPS misses analyst expectations Apr 01
Now 22% undervalued after recent price drop Mar 14
Now 20% undervalued Feb 28
Consensus EPS estimates increase by 17% Feb 17
Now 20% undervalued after recent price drop Jan 31
Hamilton Thorne Ltd. Announces Passing of Diarmaid Douglas-Hamilton, Cofounder and Chief Technology Officer Jan 25
Now 21% undervalued after recent price drop Dec 29
Hamilton Thorne Ltd. (TSXV:HTL) agreed to acquire Microptic, S.L. Dec 02
Consensus EPS estimates fall by 33% Nov 29
Hamilton Thorne Ltd. Provides Sales Guidance for the Year 2022 Nov 23
Third quarter 2022 earnings released: EPS: US$0.001 (vs US$0.002 in 3Q 2021) Nov 22
High number of new directors Nov 16
Hamilton Thorne Ltd. to Report Nine Months, 2022 Results on Nov 22, 2022 Nov 09
Consensus EPS estimates fall by 23% Aug 30
Second quarter 2022 earnings: EPS and revenues miss analyst expectations Aug 23
Hamilton Thorne Ltd. to Report Q2, 2022 Results on Aug 23, 2022 Aug 17
Hamilton Thorne Ltd. Announces CFO Changes Jul 13
Chair, President exercised options to buy CA$86k worth of stock. Jul 06
Chair, President exercised options to buy CA$886k worth of stock. Jun 16
Consensus EPS estimates fall by 20% May 26
At CA$1.40, Is Hamilton Thorne Ltd. (CVE:HTL) Worth Looking At Closely? May 25
First quarter 2022 earnings: EPS and revenues miss analyst expectations May 19
Hamilton Thorne Ltd. to Report Q1, 2022 Results on May 19, 2022 May 12
Investor sentiment deteriorated over the past week May 11
High number of new directors Apr 27
Hamilton Thorne Ltd., Annual General Meeting, Jun 14, 2022 Apr 16
Full year 2021 earnings: EPS exceeds analyst expectations Apr 08
Chair, President exercised options to buy CA$293k worth of stock. Apr 03
Hamilton Thorne Ltd. to Report Q4, 2021 Results on Apr 07, 2022 Apr 01
Is Hamilton Thorne (CVE:HTL) Using Too Much Debt? Mar 30
High number of new directors Feb 09
President recently bought CA$75k worth of stock Dec 25
President recently sold CA$635k worth of stock Dec 06
Third quarter 2021 earnings: EPS and revenues miss analyst expectations Nov 24
These 4 Measures Indicate That Hamilton Thorne (CVE:HTL) Is Using Debt Safely Oct 05
Second quarter 2021 earnings released: EPS US$0.003 (vs US$0.004 loss in 2Q 2020) Aug 21
Hamilton Thorne Ltd. (TSXV:HTL) acquired IVFTECH ApS and K4 Technology ApS for an enterprise value of approximately DKK 50 million ($8 million). Jul 16
President exercised options to buy CA$115k worth of stock. Jul 05
Should You Think About Buying Hamilton Thorne Ltd. (CVE:HTL) Now? Jun 10
Consensus EPS estimates increase to US$0.028 Jun 01
First quarter 2021 earnings released: EPS US$0.006 (vs US$0.001 in 1Q 2020) May 27
Hamilton Thorne (CVE:HTL) Will Be Hoping To Turn Its Returns On Capital Around May 15
Independent Director recently bought CA$107k worth of stock Apr 18
Is Hamilton Thorne (CVE:HTL) A Risky Investment? Apr 12
Full year 2020 earnings released: EPS US$0.007 (vs US$0.006 in FY 2019) Apr 10
Estimating The Fair Value Of Hamilton Thorne Ltd. (CVE:HTL) Mar 15
When Should You Buy Hamilton Thorne Ltd. (CVE:HTL)? Mar 01
New 90-day high: CA$1.50 Feb 17
Hamilton Thorne Ltd. Announces Board Changes Feb 10
Has Hamilton Thorne (CVE:HTL) Got What It Takes To Become A Multi-Bagger? Feb 01
Hamilton Thorne Announces Board Changes Jan 20
Announcing: Hamilton Thorne (CVE:HTL) Stock Soared An Exciting 590% In The Last Five Years Jan 19
President exercised options to buy CA$686k worth of stock. Jan 18
Are Insiders Selling Hamilton Thorne Ltd. (CVE:HTL) Stock? Jan 06
New 90-day high: CA$1.42 Dec 30
What Did Hamilton Thorne's (CVE:HTL) CEO Take Home Last Year? Dec 24
Independent Director exercised options to buy CA$139k worth of stock. Dec 16
We Think Hamilton Thorne (CVE:HTL) Can Stay On Top Of Its Debt Dec 12
Independent Director exercised options to buy CA$139k worth of stock. Dec 11 Shareholder Returns HTL CA Medical Equipment CA Market 7D 0% -0.8% 0.9% 1Y 85.1% -14.3% 15.7%
See full shareholder returns
Return vs Market: HTL exceeded the Canadian Market which returned 22.2% over the past year.
Price Volatility Is HTL's price volatile compared to industry and market? HTL volatility HTL Average Weekly Movement 1.6% Medical Equipment Industry Average Movement 13.7% Market Average Movement 8.1% 10% most volatile stocks in CA Market 17.3% 10% least volatile stocks in CA Market 2.9%
Stable Share Price: HTL has not had significant price volatility in the past 3 months compared to the Canadian market.
Volatility Over Time: HTL's weekly volatility has decreased from 8% to 2% over the past year.
About the Company Hamilton Thorne Ltd. develops, manufactures, and sells precision instruments, laboratory equipment, consumables, software, and services for the assisted reproductive technologies (ART), research, and cell biology markets. The company offers precision laser systems and imaging systems for biology markets. It also provides test laboratory and endotoxin testing services, as well as sperm assays, including Sperm Motility Index and Sperm Penetration; and fresh and cryopreserved mouse embryos supply, and technician training and proficiency testing services.
Show more Hamilton Thorne Ltd. Fundamentals Summary How do Hamilton Thorne's earnings and revenue compare to its market cap? HTL fundamental statistics Market cap CA$345.34m Earnings (TTM ) -CA$2.93m Revenue (TTM ) CA$106.84m
Earnings & Revenue Key profitability statistics from the latest earnings report (TTM) HTL income statement (TTM ) Revenue US$76.30m Cost of Revenue US$37.45m Gross Profit US$38.85m Other Expenses US$40.94m Earnings -US$2.09m
Last Reported Earnings
Sep 30, 2024
Earnings per share (EPS) -0.014 Gross Margin 50.92% Net Profit Margin -2.74% Debt/Equity Ratio 29.9%
How did HTL perform over the long term?
See historical performance and comparison
Company Analysis and Financial Data Status Data Last Updated (UTC time) Company Analysis 2024/11/29 04:15 End of Day Share Price 2024/11/29 00:00 Earnings 2024/09/30 Annual Earnings 2023/12/31
Data Sources The data used in our company analysis is from S&P Global Market Intelligence LLC . The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
Package Data Timeframe Example US Source * Company Financials 10 years Income statement Cash flow statement Balance sheet Analyst Consensus Estimates +3 years Forecast financials Analyst price targets Market Prices 30 years Stock prices Dividends, Splits and Actions Ownership 10 years Top shareholders Insider trading Management 10 years Leadership team Board of directors Key Developments 10 years
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here .
Analysis Model and Snowflake Details of the analysis model used to generate this report is available on our Github page , we also have guides on how to use our reports and tutorials on Youtube .
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources Hamilton Thorne Ltd. is covered by 10 analysts. 5 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
Analyst Institution Jim Byrne Acumen Capital Finance Partners Limited Doug Cooper Beacon Securities Limited Kyle Bauser Colliers Securities
Show 7 more analysts 
